The Finnish Faecal Microbiota Transplantation Study (FINFMT)

Summary

The objective of the study is to follow up the long term effects of faecal microbiota tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in other trials meet inclusion criteria to this study. Patients will be asked for a written consent. The outcome and possible side effects of the FMT will be followed by blood and feces samples for one year and with questionaires up to ten years after the FMT.

Conditions

• Faecal Microbiota Transplantation

Sponsors & Collaborators

• University of Helsinki

  collaborator OTHER

• Helsinki University Central Hospital

  collaborator OTHER

• Turku University Hospital

  collaborator OTHER_GOV

• Tampere University Hospital

  collaborator OTHER

• Oulu University Hospital

  collaborator OTHER

• Kuopio University Hospital

  collaborator OTHER

• South Karelia, Social and Health Care District

  collaborator OTHER

• North Karelia Central Hospital

  collaborator OTHER

• Keski-Pohjanmaa Central Hospital

  collaborator UNKNOWN

• Seinajoki Central Hospital

  collaborator OTHER

• Jyväskylä Central Hospital

  collaborator OTHER

• Kanta-Häme Central Hospital

  collaborator OTHER_GOV

• Mikkeli Central Hospital

  collaborator OTHER

• Vaasa Central Hospital, Vaasa, Finland

  collaborator OTHER

• Lapland Central Hospital

  collaborator UNKNOWN

• Satakunta Central Hospital

  collaborator OTHER

• Kymenlaakso Social and Health Services

  collaborator UNKNOWN

• Kainuu Social and Health Care Joint Authority

  collaborator OTHER

• Joint Authority for Päijät-Häme Social and Health Care

  lead OTHER

Principal Investigators

• Perttu Arkkila, PhD · Head of Department

Eligibility

Min Age

18 Years

Max Age

120 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-10-18

Primary Completion

2021-12-31

Completion

2029-01-15

Countries

• Finland

Study Locations